comparemela.com

Latest Breaking News On - Ghent university hospital - Page 4 : comparemela.com

Argenx: CHMP Recommends EC Approval For Subcutaneous Efgartigimod For Generalized Myasthenia Gravis

argenx SE (ARGX), a Dutch immunology company, Friday announced that the European Medicines Agency's Committee for Medicinal Products for Human Use or CHMP has recommended European Commission approval for Subcutaneous Efgartigimod to treat Generalized Myasthenia Gravis or gMG.

Ghent universityEuropean commissionGhent university hospitalMore such health newsEuropean medicines agencyMedicinal productsHuman useSubcutaneous efgartigimodGeneralized myasthenia gravisC approvalGeneralized myasthenia gravisHmp recommendsSubcutaneous efgartigimod

argenx Announces Positive CHMP Opinion for Subcutaneous

Positive opinion based on Phase 3 ADAPT-SC study demonstrating noninferior total IgG reduction at day 29 with subcutaneously (SC) administered.

Noord hollandUnited statesUnited kingdomErin murphyAnant murthyEuropean commissionGhent university hospitalCommittee for medicinal products human useGhent universityImmunology innovation programEuropean medicines agencyEuropean union member statesMedicinal productsHuman useGeneral managerUnion member states

argenx Announces Positive CHMP Opinion for Subcutaneous Efgartigimod for Generalized Myasthenia Gravis - argenx (NASDAQ:ARGX)

Positive opinion based on Phase 3 ADAPT-SC study demonstrating noninferior total IgG reduction at day 29 with subcutaneously (SC) administered efgartigimod, compared to intravenous (IV) administrationEuropean

Noord hollandUnited kingdomUnited statesAnant murthyErin murphyEuropean union member statesCommittee for medicinal products human useEuropean commissionGhent universityEuropean medicines agencyGhent university hospitalImmunology innovation programMedicinal productsHuman useGeneral managerUnion member states

Imec drug monitoring spin-off raises €10m seedround

Axithra, a new spin-off of imec and Ghent University, today announced a €10 million seed round, securing the first two years of R&D. Axithra develops

Roel baetsLeander van nesteWallonie entreprendreWhite fundHamamatsu photonicsGhent university hospitalPhotonics research groupEuropean society of intensive care medicineGhent universityLeander vanKurma partnersJan de waeleEuropean societyIntensive care medicineProf roel baets

New Electronics - Imec spin-off Axithra raises 10m Euro

Axithra, a spin-off of imec and Ghent University, has announced a 10 million euro seed round, securing the first two years of R&D.

Roel baetsLeander van nesteWallonie entreprendreHamamatsu photonicsPhotonics research groupWhite fundEuropean society of intensive care medicineGhent universityGhent university hospitalKurma partnersJan de waeleEuropean societyIntensive care medicine

vimarsana © 2020. All Rights Reserved.